PainReform Ltd. (PRFX)
USD 2.09
(-5.26%)
USD 2.09
(-5.26%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.93 Million USD | -19.45% |
| 2022 | 12.32 Million USD | -35.36% |
| 2021 | 19.07 Million USD | 7.15% |
| 2020 | 17.8 Million USD | 1429.3% |
| 2019 | 1.16 Million USD | 1337.04% |
| 2018 | 81 Thousand USD | -62.15% |
| 2017 | 214 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.1 Million USD | -42.13% |
| 2024 Q1 | 5.36 Million USD | -45.93% |
| 2023 Q4 | 9.93 Million USD | -8.79% |
| 2023 FY | 9.93 Million USD | -19.45% |
| 2023 Q3 | 10.88 Million USD | 30.92% |
| 2023 Q2 | 8.31 Million USD | -20.18% |
| 2023 Q1 | 10.41 Million USD | -15.49% |
| 2022 Q1 | 17.7 Million USD | -7.17% |
| 2022 FY | 12.32 Million USD | -35.36% |
| 2022 Q4 | 12.32 Million USD | -16.99% |
| 2022 Q3 | 14.85 Million USD | -7.11% |
| 2022 Q2 | 15.98 Million USD | -9.7% |
| 2021 FY | 19.07 Million USD | 7.15% |
| 2021 Q1 | 21.35 Million USD | 19.96% |
| 2021 Q3 | 20.33 Million USD | 2.52% |
| 2021 Q4 | 19.07 Million USD | -6.22% |
| 2021 Q2 | 19.83 Million USD | -7.1% |
| 2020 FY | 17.8 Million USD | 1429.3% |
| 2020 Q4 | 17.8 Million USD | 0.0% |
| 2020 Q2 | 838 Thousand USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2019 Q3 | 1.16 Million USD | 912.17% |
| 2019 Q2 | 115 Thousand USD | 0.0% |
| 2019 Q1 | 115 Thousand USD | 41.98% |
| 2019 Q4 | 1.16 Million USD | 0.0% |
| 2019 FY | 1.16 Million USD | 1337.04% |
| 2018 Q3 | 81 Thousand USD | 0.0% |
| 2018 Q4 | 81 Thousand USD | 0.0% |
| 2018 FY | 81 Thousand USD | -62.15% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | 214 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | 85.022% |
| Safety Shot Inc | 12.7 Million USD | 21.868% |
| Bright Green Corporation | 17.4 Million USD | 42.941% |
| Embecta Corp. | 1.21 Billion USD | 99.182% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 98.902% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 82.706% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 99.131% |
| Dynavax Technologies Corporation | 997.09 Million USD | 99.004% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 95.175% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 98.637% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 99.369% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 63.689% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 63.689% |
| SCYNEXIS, Inc. | 128.41 Million USD | 92.267% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | 57.063% |
| Journey Medical Corporation | 76.84 Million USD | 87.079% |
| Alpha Teknova, Inc. | 128.58 Million USD | 92.278% |
| Procaps Group, S.A. | 460.18 Million USD | 97.842% |
| Theratechnologies Inc. | 77.76 Million USD | 87.231% |
| Harrow Health, Inc. | 311.75 Million USD | 96.815% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | 33.324% |
| Biofrontera Inc. | 27.93 Million USD | 64.449% |
| DURECT Corporation | 45.18 Million USD | 78.026% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 99.295% |
| Cronos Group Inc. | 1.13 Billion USD | 99.125% |
| OptiNose, Inc. | 107.72 Million USD | 90.782% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 97.892% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 82.252% |
| RedHill Biopharma Ltd. | 23.04 Million USD | 56.914% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 97.841% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | 16.682% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 87.857% |
| Radius Health, Inc. | 1.71 Billion USD | 99.421% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 81.365% |
| ProPhase Labs, Inc. | 91.92 Million USD | 89.198% |
| Phibro Animal Health Corporation | 982.18 Million USD | 98.989% |
| Procaps Group S.A. | 460.18 Million USD | 97.842% |
| Alvotech | 950.09 Million USD | 98.955% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 77.072% |
| Viatris Inc. | 47.68 Billion USD | 99.979% |
| Rockwell Medical, Inc. | 52.17 Million USD | 80.967% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 91.592% |
| SIGA Technologies, Inc. | 254.83 Million USD | 96.103% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.771% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 96.372% |
| Shineco, Inc. | 84.17 Million USD | 88.204% |
| PetIQ, Inc. | 868.22 Million USD | 98.856% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -17.679% |
| Incannex Healthcare Limited | 17.04 Million USD | 41.749% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.695% |
| Alimera Sciences, Inc. | 153.52 Million USD | 93.532% |
| Silver Spike Investment Corp. | 88.57 Million USD | 88.789% |
| Assertio Holdings, Inc. | 286.41 Million USD | 96.533% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -66.842% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 70.618% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 68.217% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | 25.043% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 96.197% |
| Hempacco Co., Inc. | 18.04 Million USD | 44.965% |
| Talphera, Inc. | 20.39 Million USD | 51.312% |
| Alvotech | 950.09 Million USD | 98.955% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 97.555% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 99.399% |
| Currenc Group, Inc. | 141.49 Million USD | 92.982% |
| Kamada Ltd. | 351.96 Million USD | 97.179% |
| Indivior PLC | 1.95 Billion USD | 99.491% |
| Evoke Pharma, Inc. | 7.06 Million USD | -40.482% |
| Flora Growth Corp. | 23.62 Million USD | 57.97% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | 25.043% |
| Evolus, Inc. | 188.99 Million USD | 94.746% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 99.224% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 99.344% |
| Akanda Corp. | 8.83 Million USD | -12.33% |